Skip to content

Clinical trials

Phase 4 Metabolic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 4 Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20045
20053
20064
20077
20083
20092
20101
20112
20121
20131
20142
20151
20161
20181
20202
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated5
Recruiting3
Not yet recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt University3
Vanderbilt University Medical Center3
Novartis2
University of Florida2
University of Texas Southwestern Medical Center2
Ali Aminian1
Atlanta Heart Specialists, LLC1
Baylor College of Medicine1
Baylor University1
Beth Israel Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome44
Insulin Resistance16
Hypertension9
Obesity9
Schizophrenia5
Diabetes Mellitus4
Glucose Intolerance3
Psychotic Disorders3
Atherosclerosis2
Bipolar Disorder2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.